| Literature DB >> 29973859 |
Oladunni Oluwoye1,2, Emily Leickly1,2, Jordan Skalisky1,2, Sterling McPherson2,3,4, Katherine Hirchak1,2, Debra Srebnik5, John M Roll2,3, Richard K Ries5, Michael G McDonell1,2,3.
Abstract
The objective of this study was to determine whether the interaction between type of serious mental illness (SMI) and pre-treatment drinking severity, assessed by ethyl glucuronide (EtG), predicts EtG-positive urine samples submitted during treatment in outpatients with co-occurring alcohol dependence and SMI. Seventy-nine participants were randomized to treatment-as-usual or treatment-as-usual and contingency management (CM) targeting alcohol abstinence. Generalized estimating equations were used to assess the interaction of pre-treatment drinking (heavy drinking or light drinking) and SMI diagnosis (major depression, bipolar, or schizophrenia-spectrum disorders) across a 12-week treatment period. In the overall sample, the interaction of drinking severity and SMI diagnosis (p = 0.006) was associated with alcohol abstinence. Exploratory analyses of the interaction term among participants randomized to CM (n = 40; p = 0.008) were associated with alcohol abstinence during CM. Type of SMI diagnosis was associated with treatment outcomes in individuals who engaged in heavy drinking, but not light drinking, prior to treatment.Entities:
Keywords: Alcohol treatment; Co-occurring disorders; Contingency management; Ethyl glucuronide; Heavy drinking; Serious mental illness
Year: 2017 PMID: 29973859 PMCID: PMC6027641
Source DB: PubMed Journal: Int J Ment Health Addict ISSN: 1557-1874 Impact factor: 3.836